Ligand validation:4XTI

IMP: INOSINIC ACID

IMP is a Ligand Of Interest in 4XTI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XTI_IMP_B_601	81%	48%	0.106	0.957	0.97	1.06	1	2	1	0	100%	1
4XTI_IMP_A_601	72%	48%	0.109	0.933	0.98	1.06	2	3	1	0	100%	0.913
4XTD_IMP_A_601	69%	3%	0.136	0.952	3.9	2.41	6	2	1	0	100%	0.6565
2C6Q_IMP_E_1337	98%	21%	0.06	0.984	1.94	1.53	5	6	3	0	100%	1
5UWX_IMP_C_501	98%	35%	0.06	0.984	1.3	1.35	3	2	2	0	100%	1
5UZC_IMP_D_500	98%	31%	0.06	0.981	1.35	1.51	2	3	1	0	100%	1
5UPV_IMP_A_601	98%	35%	0.06	0.979	1.39	1.27	2	3	1	0	100%	1
7PVO_IMP_A_501	97%	33%	0.063	0.981	1.48	1.28	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.